科研之友
微信
新浪微博
Facebook
分享链接
摘要
To explore the capability of the amide-proton-transfer weighted (APTW) magnetic resonance imaging (MRI) in the evaluation of clinical neurological deficit at the time of hospitalization and assessment of long-term daily functional outcome for patients with acute ischemic stroke (AIS). We recruited 55 AIS patients with brain MRI acquired within 24-48 h of symptom onset and followed up with their 90-day modified Rankin Scale (mRS) score. APT weighted MRI was performed for all the study subjects to measure APTW signal quantitatively in the acute ischemic area (APTW(ipsi)) and the contralateral side (APTW(cont)). Change of the APT signal between the acute ischemic region and the contralateral side (Delta APIW) was calculated. Maximum APTW signal (APTW(max)) and minimal APTW signal (APTW(min)) were also acquired to demonstrate APTW signals heterogeneity (APTW(max-min)). In addition, all the patients were divided into 2 groups according to their 90-day mRS score (good prognosis group with mRS score <.2 and poor prognosis group with mRS score >= 2). In the meantime, Delta APTW of these groups was compared. We found that Delta APIW was in good correlation with National Institutes of Health Stroke Scale (NIHSS) score (R-2 = 0.578, p < 0.001) and 90-day mRS score (R-2 = 0.55, p 0.001). There was significant difference of Delta APTW between patients with good prognosis and patients with poor prognosis. Plus, APTW(max-min) was significantly different between two groups. These results suggested that APT weighted MRI could be used as an effective tool to assess the stroke severity and prognosis for patients with AIS, with APTW signal heterogeneity as a possible biomarker.
